[73] Yoon C, Korade Z,

Carter BD. Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factor-κB promotes Schwann cell differentiation into a myelinating phenotype. The Journal of Neuroscience. 2008;**28**(14):3738-3746. DOI: 10.1523/JNEUROSCI.4439-07.2008

[74] Limpert AS, Carter BD. Axonal neuregulin 1 type III activates NF-κB in Schwann cells during myelin formation. The Journal of Biological Chemistry. 2010;**285**(22):16614-16622. DOI: 10.1074/jbc.M109.098780

[75] Quintes S, Brinkmann BG, Ebert M, et al. Zeb2 is essential for Schwann

*Schwann Cell Plasticity in Peripheral Nerve Regeneration after Injury DOI: http://dx.doi.org/10.5772/intechopen.91805*

cell differentiation, myelination and nerve repair. Nature Neuroscience. 2016;**19**(8):1050-1059. DOI: 10.1038/ nn.4321

[76] Doddrell RDS, Dun XP, Moate RM, Jessen KR, Mirsky R, Parkinson DB. Regulation of Schwann cell differentiation and proliferation by the Pax-3 transcription factor. Glia. 2012;**60**(9):1269-1278. DOI: 10.1002/ glia.22346

[77] Gao X, Daugherty RL, Tourtellotte WG. Regulation of low affinity neurotrophin receptor (p75NTR) by early growth response (Egr) transcriptional regulators. Molecular and Cellular Neurosciences. 2007;**36**(4):501-514. DOI: 10.1016/j. mcn.2007.08.013

[78] Norrmén C, Figlia G, Pfistner P, Pereira JA, Bachofner S, Suter U. mTORC1 is transiently reactivated in injured nerves to promote c-Jun elevation and schwann cell dedifferentiation. The Journal of Neuroscience. 2018;**38**(20): 4811-4828. DOI: 10.1523/ JNEUROSCI.3619-17.2018

[79] Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1 (HIF-1) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Molecular and Cellular Biology. 2001;**21**(12):3995-4004. DOI: 10.1128/ mcb.21.12.3995-4004.2001

[80] Roczniak-Ferguson A, Petit CS, Froehlich F, et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Science Signaling. 2012;**5**(228):ra42. DOI: 10.1126/ scisignal.2002790

[81] Tiebe M, Lutz M, De La Garza A, Buechling T, Boutros M, Teleman AA. REPTOR and REPTOR-BP regulate organismal metabolism and transcription downstream of TORC1. Developmental Cell. 2015;**33**(3):272- 284. DOI: 10.1016/j.devcel.2015.03.013

[82] Park Y, Reyna-Neyra A, Philippe L, Thoreen CC. mTORC1 balances cellular amino acid supply with demand for protein synthesis through posttranscriptional control of ATF4. Cell Reports. 2017;**19**(6):1083-1090. DOI: 10.1016/j.celrep.2017.04.042

[83] Ben-Sahra I, Manning BD. mTORC1 signaling and the metabolic control of cell growth. Current Opinion in Cell Biology. 2017;**45**:72-82. DOI: 10.1016/j. ceb.2017.02.012

[84] Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;**168**(6):960-976. DOI: 10.1016/j.cell.2017.02.004

[85] Sherman DL, Krols M, Wu LMN, et al. Arrest of myelination and reduced axon growth when Schwann cells lack mTOR. The Journal of Neuroscience. 2012;**32**(5):1817-1825. DOI: 10.1523/ JNEUROSCI.4814-11.2012

[86] Norrmén C, Figlia G, Lebrun-Julien F, et al. mTORC1 controls PNS myelination along the mTORC1- RXRγ-SREBP-lipid biosynthesis axis in Schwann cells. Cell Reports. 2014;**9**(2):646-660. DOI: 10.1016/j. celrep.2014.09.001

[87] Beirowski B, Wong KM, Babetto E, Milbrandt J. MTORC1 promotes proliferation of immature Schwann cells and myelin growth of differentiated Schwann cells. Proceedings of the National Academy of Sciences of the United States of America. 2017;**114**(21):E4261-E4270. DOI: 10.1073/pnas.1620761114

[88] Figlia G, Norrmén C, Pereira JA, Gerber D, Suter U. Dual function of the PI3K-Akt-MTORC1 axis in myelination

of the peripheral nervous system. eLife. 2017;**6**:e29241. DOI: 10.7554/ eLife.29241

[89] Figlia G, Gerber D, Suter U. Myelination and mTOR. Glia. 2018;**66**(4):693-707. DOI: 10.1002/ glia.23273

[90] Sheu JY, Kulhanek DJ, Eckenstein FP. Differential patterns of ERK and STAT3 phosphorylation after sciatic nerve transection in the rat. Experimental Neurology. 2000;**166**(2):392-402. DOI: 10.1006/ exnr.2000.7508

[91] Harrisingh MC, Perez-Nadales E, Parkinson DB, Malcolm DS, Mudge AW, Lloyd AC. The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. The EMBO Journal. 2004;**23**(15):3061-3071. DOI: 10.1038/ sj.emboj.7600309

[92] Zrouri H, Le Goascogne C, Li WW, Pierre M, Courtin F. The role of MAP kinases in rapid gene induction after lesioning of the rat sciatic nerve. The European Journal of Neuroscience. 2004;**20**(7):1811-1818. DOI: 10.1111/j.1460-9568.2004.03641.x

[93] Agthong S, Kaewsema A, Tanomsridejchai N, Chentanez V. Activation of MAPK ERK in peripheral nerve after injury. BMC Neuroscience. 2006;**7**:45. DOI: 10.1186/1471-2202-7-45

[94] Lee HJ, Shin YK, Park HT. Mitogen activated protein kinase family proteins and c-jun signaling in injury-induced schwann cell plasticity. Experimental Neurobiology. 2014;**23**(2):130. DOI: 10.5607/en.2014.23.2.130

[95] Ronchi G, Haastert-Talini K, Fornasari BE, Perroteau I, Geuna S, Gambarotta G. The Neuregulin1/ErbB system is selectively regulated during peripheral nerve degeneration and regeneration. The European Journal of Neuroscience. 2016;**43**(3):351-364. DOI: 10.1111/ejn.12974

[96] Grossmann KS, Wende H, Paul FE, et al. The tyrosine phosphatase Shp2 (PTPN11) directs neuregulin-1/ ErbB signaling throughout Schwann cell development. Proceedings of the National Academy of Sciences of the United States of America. 2009;**106**(39):16704-16709. DOI: 10.1073/pnas.0904336106

[97] He Y, Kim JY, Dupree J, et al. Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination. Nature Neuroscience. 2010;**13**(12):1472-1482. DOI: 10.1038/nn.2686

[98] Newbern JM, Li X, Shoemaker SE, et al. Specific functions for ERK/MAPK signaling during PNS development. Neuron. 2011;**69**(1):91-105. DOI: 10.1016/j.neuron.2010.12.003

[99] Napoli I, Noon LA, Ribeiro S, et al. A central role for the ERK-signaling pathway in controlling schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron. 2012;**73**(4):729-742. DOI: 10.1016/j. neuron.2011.11.031

[100] Newbern JM, Snider WD. Bers-ERK Schwann cells coordinate nerve regeneration. Neuron. 2012;**73**(4):623-626. DOI: 10.1016/j. neuron.2012.02.002

[101] Parkinson DB, Dong Z, Bunting H, et al. Transforming growth factor β (TGFβ) mediates Schwann cell death in vitro and in vivo: Examination of c-Jun activation, interactions with survival signals, and the relationship of TGFβ-mediated death to Schwann cell differentiation. The Journal of Neuroscience. 2001;**21**(21):8572-8585. DOI: 10.1523/ jneurosci.21-21-08572.2001

[102] Yamauchi J, Chan JR, Shooter EM. Neurotrophin 3 activation of TrkC induces Schwann cell migration through the c-Jun N-terminal kinase pathway. Proceedings of the National Academy

*Schwann Cell Plasticity in Peripheral Nerve Regeneration after Injury DOI: http://dx.doi.org/10.5772/intechopen.91805*

of Sciences of the United States of America. 2003;**100**(SUPPL. 2):14421- 14426. DOI: 10.1073/pnas.2336152100

[103] Thakur KK, Saini J, Mahajan K, et al. Therapeutic implications of toll-like receptors in peripheral neuropathic pain. Pharmacological Research. 2017;**115**:224-232. DOI: 10.1016/j.phrs.2016.11.019

[104] Goethals S, Ydens E, Timmerman V, Janssens S. Toll-like receptor expression in the peripheral nerve. Glia. 2010;**58**(14):1701-1709. DOI: 10.1002/glia.21041

[105] Boivin A, Pineau I, Barrette B, et al. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. The Journal of Neuroscience. 2007;**27**(46):12565-12576. DOI: 10.1523/ JNEUROSCI.3027-07.2007

[106] Atanasoski S, Scherer SS, Sirkowski E, et al. ErbB2 signaling in Schwann cells is mostly dispensable for maintenance of myelinated peripheral nerves and proliferation of adult Schwann cells after injury. The Journal of Neuroscience. 2006;**26**(7):2124-2131. DOI: 10.1523/JNEUROSCI.4594-05.2006

[107] Guertin AD, Zhang DP, Mak KS, Alberta JA, Kim HA. Microanatomy of axon/glial signaling during Wallerian degeneration. The Journal of Neuroscience. 2005;**25**(13):3478-3487. DOI: 10.1523/JNEUROSCI.3766-04.2005

[108] Ronchi G, Cillino M, Gambarotta G, et al. Irreversible changes occurring in long-term denervated Schwann cells affect delayed nerve repair. Journal of Neurosurgery. 2017;**127**(4):843-856. DOI: 10.3171/2016.9.JNS16140

[109] Mahanthappa NK, Anton ES, Matthew WD. Glial growth factor 2, a soluble neuregulin, directly increases Schwann cell motility and indirectly promotes neurite outgrowth. The Journal of Neuroscience. 1996;**16**(15):4673-4683. DOI: 10.1523/ jneurosci.16-15-04673.1996

[110] Fricker FR, Bennett DL. The role of neuregulin-1 in the response to nerve injury. Future Neurology. 2011;**6**(6):809-822. DOI: 10.2217/ fnl.11.45

[111] Joshi AR, Holtmann L, Bobylev I, et al. Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP). Journal of Neuroinflammation. 2016;**13**(1):255. DOI: 10.1186/s12974-016-0711-7

[112] Zochodne DW. The challenges and beauty of peripheral nerve regrowth. Journal of the Peripheral Nervous System. 2012;**17**:1-18. DOI: 10.1111/j.1529-8027.2012.00378.x

[113] Painter MW, Brosius Lutz A, Cheng YC, et al. Diminished Schwann cell repair responses underlie age-associated impaired axonal regeneration. Neuron. 2014;**83**(2):331- 343. DOI: 10.1016/j.neuron.2014.06.016

[114] Frohnert PW, Stonecypher MS, Carroll SL. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line. Glia. 2003;**43**(2):104-118. DOI: 10.1002/glia.10232

[115] Fallon KB, Havlioglu N, Hamilton LH, Cheng TPH, Carroll SL. Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line. Journal of Neuro-Oncology. 2004;**66**(3):273-284. DOI: 10.1023/B:N EON.0000014521.28294.84

[116] Huijbregts RPH, Roth KA, Schmidt RE, Carroll SL. Hypertrophic neuropathies and malignant peripheral nerve sheath tumors in transgenic

mice overexpressing glial growth factor β3 in myelinating Schwann cells. The Journal of Neuroscience. 2003;**23**(19):7269-7280. DOI: 10.1523/ jneurosci.23-19-07269.2003

[117] Tapinos N, Ohnishi M, Rambukkana A. ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. Nature Medicine. 2006;**12**(8):961-966. DOI: 10.1038/ nm1433

[118] Fledrich R, Stassart RM, Klink A, et al. Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. Nature Medicine. 2014;**20**(9):1055-1061. DOI: 10.1038/nm.3664

[119] Manole E, Bastian A, Ristoiu V, Zurac S, Neagu M. The effects of exogenous modulation on the peripheral nerve regeneration after injury and primary surgical repair. Biomedical Journal of Scientific & Technical Research. 2018;**4**(3):1-5. DOI: 10.26717/ bjstr.2018.04.0001043
